Progyny (NASDAQ: PGNY) reported Q3 EPS of $0.16, $0.05 better than the analyst estimate of $0.11. Revenue for the quarter came in at $280.9 million versus the consensus estimate of $271.21 million.

For earnings history and earnings-related data on Progyny (PGNY) click here.